Enrique Grande, Medical Oncology Department Director at Quironsalud Madrid, Adjunct Professor at The University of Texas MD Anderson Cancer Center, shared a post on LinkedIn about a paper by Benjamin L. Maughan et al. published in European Urology:
“Liquid biopsies are reshaping GU oncology.
This comprehensive review outlines all current FDA-approved indications — showing how blood-based assays guide treatment selection, predict response, and support biomarker-driven care across genitourinary malignancies.”
Title: The Role of Liquid Biopsy in the Management of Patients with Genitourinary Malignancies
Authors: Benjamin L. Maughan, Lars Dyrskjøt, Petros Grivas, Antonio Alcaraz, Emmanuel S. Antonarakis, Mehmet A. Bilen, Trinity Bivalacqua, Matthew R. Cooperberg, Liang Cheng, Shilpa Gupta
You can read the full article in European Urology.
More posts featuring Enrique Grande.